EndoTODAY | EndoATLAS | Outpatient Clinic
Parasite | Esophagus | Stomach | Cancer | ESD
Home | Guide | Author | Subscription | Links
[Thursday Endoscopy Conference 20160922]
ÁßdzÀ¸·Î ½Å°æ°ú ÀÔ¿øÇÑ È¯ÀÚÀÇ º¹ÅëÀ¸·Î ½ÃÇàÇÑ °Ë»ç¿¡¼ ¹ß°ßµÈ º´¼ÒÀÔ´Ï´Ù. Cardia¸¦ 360µµ °¨½Î´Â mass lesion¿´½À´Ï´Ù. Á¶Á÷°Ë»ç´Â signet ring cell carcinoma·Î ³ª¿Ô½À´Ï´Ù. ¾Æ½±°Ôµµ ÀÌ¹Ì peritoneal seeding±îÁö µ¿¹ÝµÇ¾î ÀÖ¾ú½À´Ï´Ù.
2. º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï (30´ë ¿©¼º)
3. ¸é¿ª Á¤»óÀΠȯÀÚ¿¡¼ ¹ß°ßµÈ CMV esophagitis
ÀÏÀü¿¡µµ Á¤»ó ¸é¿ªÀÚÀÇ CMV ½Äµµ¿°À» ¼Ò°³ÇÑ ¹Ù ÀÖ½À´Ï´Ù. ´Ù½Ã ¿Å±é´Ï´Ù.
Odynophagia·Î ³»¿øÇϽŠ¸é¿ª±â´ÉÀÌ Á¤»óÀÎ ¼ºÀÎÀ¸·Î ½ÄµµÁ¶Á÷°Ë»ç¿¡¼ CMV esophagitis·Î È®ÁøÀ» ÇÒ ¼ö ÀÖ¾ú´ø ¿¹ÀÔ´Ï´Ù. À̹ø Áõ·Ê¿¡¼ÀÇ °í¹Î°Å¸®´Âganciclovir Åõ¿© ÈÄ ¾ÆÁÖ »¡¸® Áõ»óÀÌ ÁÁ¾ÆÁ³±â ¶§¹®¿¡ Ç×¹ÙÀÌ·¯½º ¾àÁ¦¸¦ »ç¿ë±â°£À» °áÁ¤Çϱ⠾î·Á¿ü´Ù´Â Á¡À̾ú½À´Ï´Ù. Sleisenger Ã¥¿¡´Â ´ÙÀ½°ú °°ÀÌ ±â¼úµÇ¾î ÀÖ½À´Ï´Ù. ¡°With mild CMV disease in immunocompetent adults, treatment is unnecessary. In immunocompromised patients, antiviral therapy is indicated. Ganciclovir, a guanosine nucleoside analog with a much longer intracellular half-life than that of acyclovir, has proved to be the most effective agent. The major toxic effect is bone marrow suppression, particularly granulocytopenia. Because viremia correlates with disease outcome, ganciclovir should be continued until CMV antigenemia is undetectable. For patients resistant to or intolerant of ganciclovir, alternative agents include foscarnet and cidofovir.¡± MildÇÑ °æ¿ì´Â ¾Æ´Ï¹Ç·Î ¾àÀ» »ç¿ëÇÏ´Â °ÍÀº Ÿ´çÇÏ´Ù°í »ý°¢µÇ´Âµ¥, ±× ±â°£Àº ¿©ÀüÈ÷ °í¹ÎÀÌ ¾Æ´Ò ¼ö ¾ø¾ú½À´Ï´Ù.
¸é¿ª¾ïÁ¦È¯ÀÚ¿¡¼ÀÇ Åë»óÀûÀÎ Åõ¿©±â°£Àº 10-14ÀÏÀÔ´Ï´Ù¸¸ (Åë»ó ¾àÀ» ²÷±â Àü¿¡ CMV viremia°¡ ¼Ò½ÇµÇ¾úÀ½À» È®ÀÎÇÑ´Ù), Áõ»óÀÌ ±Þ°ÝÈ÷ È£ÀüµÈ Á¤»ó¸é¿ª ¼ºÀο¡¼ÀÇ Åõ¾à±â°£ ÁöħÀº ¶Ñ·ÇÇÏÁö ¾Ê´Ù°í »ý°¢µË´Ï´Ù. Åõ¾à±â°£À» ª°Ô ÇÏ°í ³»½Ã°æ °Ë»ç¿¡¼ È£ÀüÀ» È®ÀÎÇÏ´Â °Íµµ ÇϳªÀÇ Àü·«ÀÌ µÈ´Ù°í ¿©°ÜÁý´Ï´Ù. ¿À·¡µÈ Áõ·Êº¸°í¿¡¼ ¿Å±é´Ï´Ù (Åõ¾à±â°£ÀÌ ±æ¾ú½À´Ï´Ù).
"Therapy was started with ganciclovir (5 mg/kg/day) for 15 days. The treatment was well tolerated. A control endoscopy four weeks after treatment showed that the esophageal ulcer had healed. At that time, biopsies from the distal esophagus did not show CMV intranuclear inclusion. (Altman. Dig Dis Sci 1995)"
* Âü°í: EndoTODAY ¹ÙÀÌ·¯½º ½Äµµ¿°
4. Acute hemorrhagic rectal ulcer syndrome (AHRUS)
¿ì¿ïÁõ°ú º¯ºñ°¡ ÀÖ´ø ¿©ÀÚ È¯ÀÚÀÇ º¹Åë°ú hematochezia
ºñ±³Àû °í·É¿¡¼ ¸¹ÀÌ ¹ß»ýÇÏ´Â ÁúȯÀÌ°í Á¶Á÷°Ë»ç¿¡¼ ¼Ò°ßÀÌ Æ¯Â¡ÀûÀÔ´Ï´Ù. Solitary rectal ulcer syndrome°ú ´Þ¸® ÇѹøÀÇ episode ÈÄ È£ÀüµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.
1) SMC Endoscopy Unit »ï¼º¼¿ïº´¿ø ³»½Ã°æ½Ç
2) SMC Monday GI conference »ï¼º¼¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½É¼ÒȱâÁý´ãȸ
3) SMC Thursday endoscopy conference »ï¼º¼¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.